Warner Bros. Discovery Stock (NASDAQ: WBD): Netflix Deal vs. Paramount Bid, Analyst Forecasts, and What Matters Next (Dec. 21, 2025)

Warner Bros. Discovery Stock (NASDAQ: WBD): Netflix Deal vs. Paramount Bid, Analyst Forecasts, and What Matters Next (Dec. 21, 2025)

Warner Bros. Discovery, Inc. stock has turned into one of the market’s most event-driven media trades heading into year-end. Instead of debating streaming churn or the next tentpole slate, investors are now weighing deal certainty, regulatory timelines, and the fine
Amicus Therapeutics (FOLD) Stock Today: BioMarin’s $14.50 Cash Buyout, Latest News, Analyst Forecasts, and What Comes Next (Dec. 21, 2025)

Amicus Therapeutics (FOLD) Stock Today: BioMarin’s $14.50 Cash Buyout, Latest News, Analyst Forecasts, and What Comes Next (Dec. 21, 2025)

As of Sunday, December 21, 2025, Amicus Therapeutics, Inc. (Nasdaq: FOLD) has effectively become a “deal stock” — the market is now trading the shares primarily on the odds and timing of a takeover rather than on classic biotech catalysts.
Go toTop